Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1087 | 1008 | 1087 | 999 | 1121 | 1327 |
Fund Return | 8.72% | 0.84% | 8.72% | -0.02% | 2.31% | 2.87% |
Place in category | 204 | 146 | 204 | 103 | 98 | 36 |
% in Category | 37 | 24 | 37 | 23 | 25 | 20 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CH0429081620 | 8.01B | 28.87 | 6.79 | - | ||
CH0429081638 | 8.01B | 17.63 | 4.84 | - | ||
CH0337393745 | 6.71B | 27.07 | 6.15 | - | ||
CH0017844686 | 3.5B | 15.77 | -2.17 | 2.63 | ||
CSIF CH Emerging Markets Index Blue | 3.5B | 15.87 | -2.09 | 2.72 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
UBS CH Vitainvest 50 World U | 4.36B | 7.32 | -1.50 | 2.35 | ||
Raiffeisen Pension Invest Futura BI | 4.34B | 6.47 | -2.59 | 1.75 | ||
Raiffeisen Pension Invest Futura Ba | 4.28B | 6.47 | -2.59 | 1.75 | ||
Julius Baer Institutional BVG LPP F | 3.88B | 7.56 | 0.20 | 3.25 | ||
Julius Baer Institutional BVG LPPb1 | 3.88B | 7.67 | 0.30 | 3.34 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
UBS (Irl) plc - MSCI USA ESG Leaders UCITS USD A-a | IE00063GNWK1 | 10.77 | 228.90 | -0.69% | |
UBS (Irl) ETF plc S&P 500 ESG UCITS A Cap USD | IE00BHXMHL11 | 5.69 | 41.91 | -0.73% | |
Nestle | CH0038863350 | 2.94 | 74.68 | -0.03% | |
Novartis | CH0012005267 | 2.68 | 90.26 | 0.00% | |
Roche Holding Participation | CH0012032048 | 2.37 | 274.90 | +0.18% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review